What is Eli Lilly's other working capital?

Eli Lilly (LLY) reported other working capital of -$175M in Q1 2026.

How has Eli Lilly's other working capital changed year-over-year?

Eli Lilly's other working capital decreased by 136.9% year-over-year, from $474M to -$175M.

What is the long-term trend for Eli Lilly's other working capital?

Over 2 years (2021 to 2023), Eli Lilly's other working capital has grown at a -33.8% compound annual growth rate (CAGR), from $727.4M to $319M.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Eli Lilly LLY Other Working Capital

Other Working Capital at other companies

AmgenAMGN

$67M+34.0%

Cardinal HealthCAH

$63M—

MannkindMNKD

$62K—

McKessonMCK

-$827M-83.8%

ExelixisEXEL

$2.02M-57.8%

Lexicon PharmaceuticalsLXRX

$581K-62.3%

Other financials

Income statement

See full

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

See full

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

See full

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

See full

Market cap$1.07T+51.7%

Enterprise value$1.11T+49.3%

P/E42.3×-8.8×

P/S14.8×+1.6×

Profitability

See full

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

See full

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eli Lilly's other working capital?: Eli Lilly (LLY) reported other working capital of -$175M in Q1 2026.
How has Eli Lilly's other working capital changed year-over-year?: Eli Lilly's other working capital decreased by 136.9% year-over-year, from $474M to -$175M.
What is the long-term trend for Eli Lilly's other working capital?: Over 2 years (2021 to 2023), Eli Lilly's other working capital has grown at a -33.8% compound annual growth rate (CAGR), from $727.4M to $319M.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.